FDA Inspection 615708 — Los Angeles General Medical Center

Los Angeles General Medical Center — FEI 2015676

The FDA completed an inspection of Los Angeles General Medical Center on September 30, 2009 in Los Angeles, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 30, 2009
Fiscal Year
2009
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Los Angeles, CA (United States)

Citations

IDCFRDescription
922521 CFR 606.171Biological product deviation report
9821 CFR 606.100(c)Thorough investigations